응고 마커 시장 보고서(2026년)
Coagulation Markers Global Market Report 2026
상품코드 : 1942579
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,759,000
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,770,000
PDF & Excel (Site License) help
PDF & Excel 보고서를 동일 기업의 동일 사업장 내의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,780,000
PDF & Excel (Enterprise License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 문서의 일부나 표는 Copy & Paste 가능합니다만 챕터 전체는 불가합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF·Excel 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

응고 마커 시장 규모는 최근, 현저한 성장을 달성하고 있습니다. 2025년 12억 4,000만 달러에서 2026년에는 13억 2,000만 달러로, CAGR 6.8%로 확대가 전망되고 있습니다. 지난 수년간의 성장세는 혈전성 질환 발생률 증가, 심혈관 질환 유병률 증가, 임상현장에서의 D-dimer 검사 보급 확대, 병원 진단검사실 확충, 응고 관련 합병증에 대한 인식 개선 등이 주요 요인으로 꼽힙니다.

응고 마커 시장 규모는 향후 수년간 강력한 성장이 전망됩니다. 2030년에는 16억 7,000만 달러에 달하며, CAGR은 6.1%에 달할 전망입니다. 예측 기간 중의 성장은 응고 위험이 높은 고령화 인구 증가, 신속한 진단 판단에 대한 수요 증가, 응급 및 외상 치료 서비스 확대, 예방적 혈전 위험 평가에 대한 관심 증가, 첨단 응고 검사 기술의 채택 증가에 기인하는 것으로 추정됩니다. 예측 기간 중 주요 동향으로는 조기 및 정확한 혈전증 검출에 대한 수요 증가, 응급 및 중환자 치료 분야에서의 응고 마커 사용 확대, 신속한 현장 응고 검사 도입 증가, 외상 및 수술 분야에서의 응고 마커 검사 확대, 일상적인 진단에서 응고 검사 통합 촉진 등을 들 수 있습니다.

혈액 질환의 유병률이 증가함에 따라 응고 마커 시장은 큰 폭의 성장이 예상됩니다. 이러한 질환은 혈액의 정상적인 기능에 영향을 미치는 다양한 질환을 포함하며, 고령화, 인지력 향상, 진단 능력 향상 등의 요인으로 인해 유병률이 증가하고 있습니다. 응고 마커는 혈우병, 혈전증 등의 질환에서 응고 기능 평가, 이상 징후 감지, 치료 효과 모니터링을 통해 이들 질환의 진단 및 관리에 중요한 역할을 합니다. 예를 들어 백혈병 재단은 2024년 5월, 2035년까지 혈액암 및 혈액 질환을 앓고 있는 호주인의 수가 27만5천 명을 넘어설 것으로 예상하고 있으며, 이는 응고 마커에 대한 수요 증가를 강조하고 있습니다.

응고 마커 시장의 주요 기업은 혈전 관련 질환의 진단 속도와 정확도를 높이기 위해 D-dimer 키트와 같은 기술적으로 진보된 솔루션 개발에 주력하고 있습니다. D다이머 키트는 혈전 용해시 생성되는 단백질 단편인 D다이머의 농도를 측정하는 진단 툴로, 심부정맥혈전증, 폐색전증 등 혈전 관련 질환의 확인 및 평가에 도움이 됩니다. 예를 들어 2024년 7월 미국 바이오테크 기업 바이오노트(Bionote Inc.)는 'Vcheck D-dimer 5Tests/Kit'를 출시했습니다. 이 면역 진단 툴은 수의학용으로 설계되어 키트당 5회 검사할 수 있으며, 혈전 형성과 분해의 주요 마커인 D-다이머 농도를 측정합니다. 이를 통해 동물병원에서 혈전증, 패혈증, DIC(파종성혈관내응고증후군) 등의 질병 진단을 지원합니다.

목차

제1장 개요

제2장 시장의 특징

제3장 시장 공급망 분석

제4장 세계 시장 동향과 전략

제5장 최종 용도 산업의 시장 분석

제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의에 의한 공급망에 대한 영향, Covid가 시장에 미치는 영향을 포함한 거시경제 시나리오

제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석

제8장 시장의 세계 TAM(Total Addressable Market)

제9장 시장 세분화

제10장 지역별·국가별 분석

제11장 아시아태평양 시장

제12장 중국 시장

제13장 인도 시장

제14장 일본 시장

제15장 호주 시장

제16장 인도네시아 시장

제17장 한국 시장

제18장 대만 시장

제19장 동남아시아 시장

제20장 서유럽 시장

제21장 영국 시장

제22장 독일 시장

제23장 프랑스 시장

제24장 이탈리아 시장

제25장 스페인 시장

제26장 동유럽 시장

제27장 러시아 시장

제28장 북미 시장

제29장 미국 시장

제30장 캐나다 시장

제31장 남미 시장

제32장 브라질 시장

제33장 중동 시장

제34장 아프리카 시장

제35장 시장 규제 상황과 투자환경

제36장 경쟁 구도와 기업 개요

제37장 기타 대기업과 혁신적 기업

제38장 세계의 시장 경쟁 벤치마킹과 대시보드

제39장 주요 합병과 인수

제40장 시장의 잠재력이 높은 국가, 부문, 전략

제41장 부록

KSA
영문 목차

영문목차

Coagulation markers are substances in the blood that provide insight into the coagulation or clotting processes. These markers play a crucial role in diagnosing and monitoring various coagulation disorders, assessing the risk of bleeding or thrombosis, and guiding appropriate treatment strategies.

The main products used as coagulation markers include the D-dimer assay and the fibrinogen assay. The D-dimer assay is a blood test that measures the presence of D-dimer, a protein fragment formed when a blood clot breaks down. This test can utilize different sample types such as plasma or whole blood, employing technologies such as fluorescence immunoassay, enzyme-linked immunosorbent assay (ELISA), rapid tests, and particle-enhanced immunoturbidimetric assay. It is applied in conditions such as deep venous thrombosis (DVT), pulmonary embolism (PE), disseminated intravascular coagulation (DIC), trauma, and others. End users of these assays include hospitals, specialty clinics, academic and research institutes, and diagnostic laboratories.

Tariffs are impacting the coagulation markers market by increasing costs for imported reagents, assay kits, antibodies, and laboratory consumables used in d-dimer and fibrinogen testing. These cost pressures have particularly affected immunoassay-based and automated testing segments, with asia-pacific and europe facing greater exposure due to global reagent supply chains. Increased tariffs have raised procurement costs for hospitals and diagnostic laboratories and influenced test pricing. However, tariffs have also encouraged local reagent manufacturing, alternative sourcing, and regional production expansion, supporting long-term supply chain stability.

The coagulation markers market research report is one of a series of new reports from The Business Research Company that provides coagulation markers market statistics, including coagulation markers industry global market size, regional shares, competitors with a coagulation markers market share, detailed coagulation markers market segments, market trends and opportunities, and any further data you may need to thrive in the coagulation markers industry. This coagulation markers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The coagulation markers market size has grown strongly in recent years. It will grow from $1.24 billion in 2025 to $1.32 billion in 2026 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to rising incidence of thrombotic disorders, increasing prevalence of cardiovascular diseases, growing use of d-dimer testing in clinical practice, expansion of hospital diagnostic laboratories, improved awareness of coagulation-related complications.

The coagulation markers market size is expected to see strong growth in the next few years. It will grow to $1.67 billion in 2030 at a compound annual growth rate (CAGR) of 6.1%. The growth in the forecast period can be attributed to aging population with higher clotting risk, increasing demand for rapid diagnostic decision-making, expansion of emergency and trauma care services, growing focus on preventive thrombotic risk assessment, rising adoption of advanced coagulation testing technologies. Major trends in the forecast period include rising demand for early and accurate thrombosis detection, increasing use of coagulation markers in emergency and critical care, growing adoption of rapid and point-of-care coagulation testing, expansion of coagulation marker testing in trauma and surgical settings, increasing integration of coagulation testing in routine diagnostics.

The coagulation markers market is expected to grow significantly due to the increasing prevalence of blood disorders. These disorders encompass various conditions that impact the blood's ability to function properly, and their prevalence is rising due to factors such as aging populations, improved awareness, and enhanced diagnostic capabilities. Coagulation markers play a crucial role in diagnosing and managing these disorders by evaluating clotting function, detecting abnormalities, and monitoring treatment effectiveness for conditions such as hemophilia and thrombosis. For example, the Leukaemia Foundation reported in May 2024 that the number of Australians living with blood cancers or disorders is projected to surpass 275,000 by 2035, highlighting the escalating demand for coagulation markers.

Leading companies in the coagulation markers market are focusing on creating technologically advanced solutions, such as D-dimer kits, to enhance the speed and accuracy of diagnosing blood clot-related conditions. D-dimer kits are diagnostic tools used to measure the levels of D-dimer, a protein fragment produced during the dissolution of a blood clot, which helps in identifying and evaluating clot-related disorders like deep vein thrombosis and pulmonary embolism. For example, in July 2024, Bionote Inc., a US-based biotechnology firm, launched the Vcheck D-dimer 5Tests/Kit. This immunodiagnostic tool, designed for veterinary use, provides five tests per kit to measure D-dimer levels, a key marker for blood clot formation and breakdown. It helps diagnose conditions such as thrombosis, sepsis, and DIC in veterinary clinics.

In January 2023, Thermo Fisher Scientific Inc., a US-based biotechnology company, acquired The Binding Site Group for approximately $2.8 billion (£2.3 billion). This acquisition aims to strengthen Thermo Fisher's Specialty Diagnostics portfolio by enhancing cancer diagnostics, particularly in multiple myeloma, and driving growth in the expanding diagnostics market. The Binding Site Group, a UK-based medical equipment manufacturer, specializes in providing coagulation markers.

Major companies operating in the coagulation markers market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, W L Gore & Associates Inc, Lepu Medical Technology Beijing Co Ltd, MicroPort Scientific Corporation, Berlin Heart GmbH, Syncardia Systems LLC, Occlutech Holding AG, Sahajanand Medical Technologies Pvt Ltd, Xeltis AG, Procyrion Inc, Heartstitch Inc, Cardia Inc, OSYPKA Medical GmbH, On-X Life Technologies Inc, Ventracor Limited, HemoFlow Technologies, NuPulseCV Inc

North America was the largest region in the coagulation markers market in 2025. The regions covered in the coagulation markers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the coagulation markers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The coagulation markers market consists of revenues earned by entities providing services such as manufacturing and distribution of coagulation marker testing kits, diagnostic services, research and development of new coagulation markers, and consulting services. The market value includes the value of related goods sold by the service provider or included within the service offering. The coagulation markers market also includes sales of coagulation testing kits, point-of-care testing devices, and software solutions for data management and analysis. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Coagulation Markers Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses coagulation markers market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for coagulation markers ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The coagulation markers market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

2. Coagulation Markers Market Characteristics

3. Coagulation Markers Market Supply Chain Analysis

4. Global Coagulation Markers Market Trends And Strategies

5. Coagulation Markers Market Analysis Of End Use Industries

6. Coagulation Markers Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Coagulation Markers Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

8. Global Coagulation Markers Total Addressable Market (TAM) Analysis for the Market

9. Coagulation Markers Market Segmentation

10. Coagulation Markers Market Regional And Country Analysis

11. Asia-Pacific Coagulation Markers Market

12. China Coagulation Markers Market

13. India Coagulation Markers Market

14. Japan Coagulation Markers Market

15. Australia Coagulation Markers Market

16. Indonesia Coagulation Markers Market

17. South Korea Coagulation Markers Market

18. Taiwan Coagulation Markers Market

19. South East Asia Coagulation Markers Market

20. Western Europe Coagulation Markers Market

21. UK Coagulation Markers Market

22. Germany Coagulation Markers Market

23. France Coagulation Markers Market

24. Italy Coagulation Markers Market

25. Spain Coagulation Markers Market

26. Eastern Europe Coagulation Markers Market

27. Russia Coagulation Markers Market

28. North America Coagulation Markers Market

29. USA Coagulation Markers Market

30. Canada Coagulation Markers Market

31. South America Coagulation Markers Market

32. Brazil Coagulation Markers Market

33. Middle East Coagulation Markers Market

34. Africa Coagulation Markers Market

35. Coagulation Markers Market Regulatory and Investment Landscape

36. Coagulation Markers Market Competitive Landscape And Company Profiles

37. Coagulation Markers Market Other Major And Innovative Companies

38. Global Coagulation Markers Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Coagulation Markers Market

40. Coagulation Markers Market High Potential Countries, Segments and Strategies

41. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기